Edwards v. Novartis Consumer Health, No. X06-Cv-01-0167425s (Jul. 15, 2002)

2002 Conn. Super. Ct. 8920
CourtConnecticut Superior Court
DecidedJuly 15, 2002
DocketNo. X06-CV-01-0167425S
StatusUnpublished

This text of 2002 Conn. Super. Ct. 8920 (Edwards v. Novartis Consumer Health, No. X06-Cv-01-0167425s (Jul. 15, 2002)) is published on Counsel Stack Legal Research, covering Connecticut Superior Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Edwards v. Novartis Consumer Health, No. X06-Cv-01-0167425s (Jul. 15, 2002), 2002 Conn. Super. Ct. 8920 (Colo. Ct. App. 2002).

Opinion

[EDITOR'S NOTE: This case is unpublished as indicated by the issuing court.]

MEMORANDUM OF DECISION RE: MOTIONS TO STRIKE ##161, 162, 163, 164, 165 and 167
The plaintiffs, David Edwards and his wife, Annamarie Edwards, in their revised complaint dated January 29, 2002, have proceeded under the Connecticut Product Liability Act, General Statutes § 52-572m et CT Page 8921 seq. (CPLA) against a number of manufacturers and distributors of products containing phenylpropanolamine (PPA). The complaint alleges that David Edwards had a stroke as a result of his ingestion of several different PPA-containing products manufactured, distributed and sold by the defendants. The products that Mr. Edwards injested included Tavist-D, a cough/cold medication; Dexatrim, an appetite suppressant; and Robitussin, a cough/cold medication. The plaintiffs allege that the ingestion of Tavist-D, Dexatrim and Robitussin, all containing PPA, during a period from December 3rd through December 5, 1996, resulted in Mr. Edwards suffering a hemorrhagic stroke.

A number of the defendants have moved to strike counts asserted against them under the Connecticut Unfair Trade Practices Act, General Statutes § 42-110a et seq. (CUTPA) and a civil conspiracy theory. The defendant Arthur Drug Stores, Inc. has moved to strike the claim for punitive damages.

"The purpose of a motion to strike is to contest . . . the legal sufficiency of the allegations of the complaint . . . to state a claim upon which relief can be granted. . . (Citations omitted; internal quotation marks omitted.) Peter-Michael, Inc. v. Sea Shell Associates,244 Conn. 269, 270, 709 A.2d 558 (1998). "A motion to strike admits all facts well pleaded." Parsons v. United Technology Corp., 243 Conn. 66,68, 700 A.2d 655 (1997). "In deciding upon a motion to strike . . . a trial court must take the facts to be those alleged in the complaint . . . and cannot be aided by the assumption of any facts not therein alleged." (Citations omitted; internal quotation marks omitted.)Liljedahl Brothers, Inc. v. Grigsby, 215 Conn. 345, 348 576 A.2d 148 (1990). "[A motion to strike] does not admit legal conclusions or the truth or accuracy of opinions stated in the pleadings. . . ." (Citations omitted; emphasis omitted.) Mingachos v. CBS, Inc., 196 Conn. 91, 108,491 A.2d 368 (1985). "The court must construe the facts in the complaint most favorably to the plaintiff." (Internal quotation marks omitted.)Faulkner v. United Technologies Corp., 240 Conn. 576, 580, 693 A.2d 293 (1997). "Thus, [i]f facts provable in the complaint would support a cause of action, the motion to strike must be denied. . . ." (Citation omitted; internal quotation marks omitted.) Gazo v. Stamford,255 Conn. 245, 260, 765 A.2d 245 (2001). "A motion to strike is properly granted if the complaint alleges mere conclusions of law that are unsupported by the facts alleged." (Citations omitted.) NovametrixMedical Systems v. BOC Group, Inc., 224 Conn. 210, 215, 618 A.2d 25 (1992).

CUTPA CLAIMS

The Connecticut General Statutes provide that a "product liability CT Page 8922 claim includes [all claims alleging a product seller's misrepresentation or non-disclosure regarding the quality or safety of a product and] all claims or actions brought for personal injury, death or property damage caused by the manufacture, construction, design, formula, preparation, assembly, installation, testing, warnings, instructions, marketing, packaging or labeling of any product." General Statutes § 52-572m (b). The CPLA further provides that a products liability claim "shall be in lieu of all other claims against product sellers." General Statutes § 52-572n (a). The Connecticut Supreme Court has interpreted this language in the CPLA to find it "unequivocal" that "[t]he legislature clearly intended to make our product liability act an exclusive remedy for claims falling within its scope." Winslow v. Lewis-Shepard, Inc.,212 Conn. 462, 471, 562 A.2d 517 (1989).

In determining what falls within the scope of a CPLA claim, this court has, on two prior occasions, adopted the functional equivalence test. SeeBarry v. Quality Steel Products, Inc., Superior Court, Complex Litigation Docket, judicial district of Waterbury, Docket No. 153059 (October 29, 1999, McWeeny, J.) (25 Conn.L.Rptr. 549), and Sit v. Dighello Bros.Auto Sales, Superior Court, Complex Litigation Docket, judicial district of Waterbury, Docket No. 149919 (March 13, 2000, McWeeny, J.).

In the instant case, the CUTPA claims are merely the incorporation of the CPLA claims. Essentially, the plaintiffs allege in their CUPTA claims that the defendants have manufactured and made misrepresentations about the nature, quality and safety of their products. This is especially the case with respect to the defendants who are alleged to have sold the products. The CUTPA allegations on which the plaintiffs rely in opposition to the motions to strike merely recast the business practice of putting the PPA-containing products into the stream of commerce as a business practice that violates CUTPA. The CUTPA claims are classic CPLA claims of misrepresentation or non-disclosure or failure to warn or instruct concerning over-the-counter medications. They are the functional equivalents of the CPLA claims.

The plaintiffs also argue that the CUTPA claims should be allowed to go forward because of the difference in relief afforded by a CUTPA claim as opposed to a claim under the CPLA. This argument highlights the need for CPLA to be the exclusive remedy for such claims. Under the CPLA, punitive damages are available when caused by the product seller's "reckless disregard for the safety of product users." General Statutes § 52-240b. By such statutory provision, punitive damages are limited to an amount equal to twice the plaintiff's compensatory damages. Reasonable attorneys' fees are available pursuant to General Statutes § 52-240a

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Governors Grove Condominium Ass'n v. Hill Development Corp.
414 A.2d 1177 (Connecticut Superior Court, 1980)
Fair Winds Manor v. Commonwealth
514 A.2d 642 (Commonwealth Court of Pennsylvania, 1986)
Mingachos v. CBS, Inc.
491 A.2d 368 (Supreme Court of Connecticut, 1985)
Winslow v. Lewis-Shepard, Inc.
562 A.2d 517 (Supreme Court of Connecticut, 1989)
Liljedahl Bros. v. Grigsby
576 A.2d 149 (Supreme Court of Connecticut, 1990)
Novametrix Medical Systems, Inc. v. BOC Group, Inc.
618 A.2d 25 (Supreme Court of Connecticut, 1992)
Faulkner v. United Technologies Corp.
693 A.2d 293 (Supreme Court of Connecticut, 1997)
Parsons v. United Technologies Corp.
700 A.2d 655 (Supreme Court of Connecticut, 1997)
Peter-Michael, Inc. v. Sea Shell Associates
709 A.2d 558 (Supreme Court of Connecticut, 1998)
Gazo v. City of Stamford
765 A.2d 505 (Supreme Court of Connecticut, 2001)
Ames v. Sears, Roebuck & Co.
514 A.2d 352 (Connecticut Appellate Court, 1986)
Gill v. Petrazzuoli Bros.
521 A.2d 212 (Connecticut Appellate Court, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
2002 Conn. Super. Ct. 8920, Counsel Stack Legal Research, https://law.counselstack.com/opinion/edwards-v-novartis-consumer-health-no-x06-cv-01-0167425s-jul-15-2002-connsuperct-2002.